To embed, copy and paste the code into your website or blog:
Although vaccine rollout began slowly in the United States, millions of people are now being vaccinated against COVID-19 per day. As individuals receive the vaccine, states have been collecting personal health data in individual immunization registries. Experts say this data collection is essential to effectively monitor vaccination progress, report adverse reactions, compare vaccine efficacy in cross sections of the population, and keep track of who needs second doses and when.
Although states have traditionally been responsible for collecting immunization data without federal intervention, some say the global scale of the pandemic and the need to understand vaccination progress nationally require greater federal intervention in tracking immunization data. In December 2020, the U.S. Centers for Disease Control and Prevention (CDC) began asking states to enter into Data Use and Sharing Agreements that would require states
Tuesday, April 20, 2021
Although vaccine rollout began slowly in the United States, millions of people are now being vaccinated against COVID-19 per day. As individuals receive the vaccine, states have been collecting personal health data in individual immunization registries. Experts say this data collection is essential to effectively monitor vaccination progress, report adverse reactions, compare vaccine efficacy in cross sections of the population, and keep track of who needs second doses and when.
Although states have traditionally been responsible for collecting immunization data without federal intervention, some say the global scale of the pandemic and the need to understand vaccination progress nationally require greater federal intervention in tracking immunization data. In December 2020, the U.S. Centers for Disease Control and Prevention (CDC) began asking states to enter into Data Use and Sharing Agreements that would require states to share vaccination dat
Healthcare Innovation Through The Lens Of Interoperability And Privacy forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
LOS ANGELES, April 6, 2021 /PRNewswire/ Apotheka Systems Inc. announced they have been awarded a critical Patent Methods, Systems, and Storage Media For Managing Patient Information Using a Blockchain Network by the U.S. Patent and Trademark Office ( USPTO ) U.S. Patent No. 10,885,170 issued on January 5
th, 2021.
This marks another milestone in the Healthcare industry by making Apotheka s Blockchain technology an integral part of patient data management in era of increased challenges around security, identification and integrity.
an integral part of patient data management in era of increased challenges around security, identification and integrity
Apotheka s patent facilitates capturing key patient identification data points like name, date of birth, social security number to include biometric information like fingerprints, iris scans and combines them to create unique encryption and master in turn creating hash confidentiality, in
Bluefin Recognized for Payments Security Innovation in 2021 FinTech Breakthrough Awards Program
Share Article
Bluefin s ShieldConex wins Best Financial Transaction Security Platform We are incredibly thrilled to have Bluefin and ShieldConex recognized by FinTech Breakthrough in the 2021 FinTech Breakthrough Awards program, said John M. Perry, CEO, Bluefin. ATLANTA (PRWEB) March 16, 2021 Bluefin, the recognized leader in encryption and tokenization technologies for payment and data security, today announced that its ShieldConex® Data Security Platform has been selected as winner of the “Best Financial Transaction Security Platform” award in the fifth annual FinTech Breakthrough Awards program conducted by FinTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global FinTech market today.